Mynx Sealant: The Science Behind the Mynx
The Mynx Vascular Closure Device represents a new approach to vascular
closure through targeted placement of the Mynx sealant, a conformable,
resorbable material that allows for natural tissue healing without any
residual metallic or animal-based implants that may cause intravascular
complications.
The Sealant
The Mynx sealant consists of polyethylene glycol (PEG), a water-soluble, bio-inert, non-thrombogenic polymer known for its well-established safety profile. PEG is commonly used in a wide range of medical products from gel caps to cranial sealing (Duraseal™, Covidien).
How It Works
When delivered to the tissue tract, the freeze-dried Mynx sealant instantly absorbs blood and fluids from the arteriotomy and conforms to the tract. The hydrated, porous sealant provides immediate hemostasis by swelling 3-4 times its size. When fully expanded, the sealant is 95% blood and fluids and 5% PEG. Within 30 days, the sealant dissolves, leaving nothing behind but a healed artery.
The Sealant
The Mynx sealant consists of polyethylene glycol (PEG), a water-soluble, bio-inert, non-thrombogenic polymer known for its well-established safety profile. PEG is commonly used in a wide range of medical products from gel caps to cranial sealing (Duraseal™, Covidien).
When delivered to the tissue tract, the freeze-dried Mynx sealant instantly absorbs blood and fluids from the arteriotomy and conforms to the tract. The hydrated, porous sealant provides immediate hemostasis by swelling 3-4 times its size. When fully expanded, the sealant is 95% blood and fluids and 5% PEG. Within 30 days, the sealant dissolves, leaving nothing behind but a healed artery.
